Steele Elisa sold $231K of PCOR

Steele Elisa sold 3,337 shares of PROCORE TECHNOLOGIES, INC. (PCOR) at $69.10 ($0.23M total) on 2026-11-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Steele Elisa
Published Nov 7, 2026, 1:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 7, 2026, 1:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PCOR
Bearish
medium confidence
Mentioned
$PCOR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PCORBearishLow
01

Why it matters

The disclosed sale may cause short‑term price pressure but is unlikely to affect long‑term fundamentals.

02

Market read

Insider sale of modest size; limited trading relevance.

03

What to watch

Potential upcoming dilution or secondary offering not disclosed.

Relevance 3/10Novelty 3/10Timing: today

Background

Form 4 filing by a Procore director discloses a 10b5‑1 planned sale of shares.

Company-level read

Ticker impact

$PCORBearishMedium confidence
Context

Director Elisa Steele sold 3,337 shares of Procore Technologies for $230,586, a 10b5‑1 planned open‑market sale.

Expected impact

potential slight downward pressure as the market prices the insider sell.

Evidence & confidence

A director sold $230k worth of stock; while the amount is modest, insider sales can prompt short‑term caution.

Market effects

Minimal impact on the construction‑software sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be routine and not indicative of future performance.

Key entities

  • Procore Technologies, Inc.

    Provider of construction management software.

  • Elisa Steele

    Director of Procore Technologies.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PCORHighAI 8/10

Procore Technologies Q3 Earnings Call Highlights

Procore (NYSE: PCOR) raised its Q4 revenue outlook to $420M-$422M, including $19M from DroneDeploy, and increased its full-year revenue forecast to $1.557B-$1.559B. The company also boosted its full-year non-GAAP operating margin outlook by 50 basis points. Procore completed its $845M acquisition of DroneDeploy and introduced AI-powered products, including a voice-first mobile app in beta.

$PCORMed

BMO raises Procore stock price target on strong execution

BMO Capital raised its price target on Procore (NYSE:PCOR) to $86 from $67, citing strong Q3 results, strategic wins, and growth potential. The stock trades near its 52-week high. Procore reported $1.49B revenue over the last 12 months, with 16.5% growth and an 80% gross margin. Analysts revised earnings upwards, and several firms raised their price targets.

$PCORHighAI 8/10

Procore Technologies Inc (PCOR) Q3 2026 Earnings Call Highlights: Revenue Accelerates

Procore Technologies (PCOR) reported Q3 2026 earnings with Q4 organic revenue growth guided to 15.4%, down from 17.1% in Q3. DroneDeploy acquisition impacted margins, with Q4 non-GAAP operating margin guided at 15.5%-16%. Free cash flow margin for FY26 is expected at 18%, affected by $23M in one-time DroneDeploy closing costs. CEO Ajei Gopal attributed growth to product enhancements and AI offerings, while CFO Rachel Pyles noted broad-based growth across customer segments and regions.

$PCORHighAI 8/10

Why is Procore Technologies stock surging today?

Procore Technologies (PCOR) stock rose 19% after Q3 2026 earnings beat expectations, with revenue of $402M (up 18.7% YoY) and adjusted EPS of $0.51. The company raised full-year revenue guidance to $1.557B-$1.559B and announced a $300M share buyback program. Analysts increased price targets, with Stifel at $85, JPMorgan at $74, and Mizuho at $68. Organic revenue growth accelerated to 17.1% in Q3. The rally occurred amid a broader market uptick following U.S. midterm elections.